![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Novo Nordisk | driving change to defeat serious chronic diseases
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
Careers - Novo Nordisk
At Novo Nordisk, you will have the opportunity to build a life-changing career in a global business environment. Join us and make a difference.
Who we are - Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in discovering and developing treatment for serious chronic disease, like diabetes and obesity.
Find a job - Novo Nordisk
Build a life-changing career in a global business environment. Novo Nordisk offers a broad range of job opportunities across borders and job functions.
Our products - Novo Nordisk
Overview of Novo Nordisk pharmaceutical products within diabetes, obesity, haemophilia, human growth hormone and hormone replacement therapy.
Our medicines | Diabetes medications | Obesity medication - Novo …
In some cases, healthcare professionals and patients can visit local Novo Nordisk websites to find out more about our medicines. Please note that in some countries we are not allowed to provide very much, or sometimes any, information on our prescription medicines so you should seek alternative trustworthy sources.
Contact us - Novo Nordisk
Corporate Headquarters, Tel: +45 4444 8888, Novo Nordisk A/S, Novo Allé, 2880 Bagsvaerd, Denmark
Novo Nordisk pens and needles | insulin pens
Injection pens and injection needles from Novo Nordisk for diabetes, obesity and growth hormone deficiency. See the types of insulin pens available here and learn how to use our insulin pens.
Our heritage | Novo Nordisk | Driving change
Our history spans a century and it all began with two small Danish companies, Nordisk Insulinlaboratorium and Novo Terapeutisk Laboratorium. After hearing of the discovery of insulin in 1921, Danish Nobel laureate August Krogh and …
R&D pipeline - Novo Nordisk
At Novo Nordisk, our R&D pipeline reflects our long-standing commitment to driving change to defeat diabetes and other serious chronic conditions. Our scientists are currently working on novel and innovative treatments to address the unmet needs of people living with diabetes, obesity, cardiovascular disease, haemophilia, growth disorders and ...